Dr. Gary Miller Proulx, MD

Dr. Proulx practices at Holy Family Hospital - Haverhill in Haverhill, Massachusetts.

Dr. Proulx's NPI, 1194798165, was assigned on February 9, 2006. Dr. Proulx graduated from Harvard Medical School in 1992. Dr. Proulx holds New York license 206678-1.

Dr. Proulx's primary practice is Holy Family Hospital - Haverhill, at 140 Lincoln Ave, Haverhill, MA 01830 in Essex County. The practice phone is (978) 946-8366.

Dr. Proulx's primary practice is Holy Family Hospital - Haverhill in Haverhill, Massachusetts. Dr. Proulx is also affiliated with Merrimack Health Methuen Hospital. The medical group on file is Steward Medical Group. Dmand AI also links Dr. Proulx to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Proulx practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Proulx's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Proulx's licenses on file in 2 states: New York and Pennsylvania.

CMS data shows 109 Medicare services from Dr. Proulx across 2 procedure codes in 2024, all of them office visits, for 96 Medicare patients. Medicare paid $5,968 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Dr. Proulx in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Proulx's median patient age at 69, with 50% women.

In 2023, Dr. Proulx wrote 41 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $764 in total drug cost. In 2022, CMS named 51 claims across 2 drugs.

Dmand AI links 4 papers to Dr. Proulx, published from 2010 to 2018. Dr. Proulx's most frequent co-authors are Harish Gangaram Ahuja, MD, William C. Dooley, MD and Steven C. Lane, MD.

Dmand AI links Dr. Proulx to 6 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms and Breast Carcinoma In Situ. Xoft, Inc. sponsors the most, 2.

CMS Open Payments shows 25 general payments to Dr. Proulx from 13 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 74% of the total. iCAD, Inc paid the most, $3,700.

Dr. Proulx graduated from Harvard Medical School in 1992.